# Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants

> **NCT02448004** · PHASE1 · COMPLETED · sponsor: **Janssen Cilag N.V./S.A.** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-63623872

## Key facts

- **NCT ID:** NCT02448004
- **Lead sponsor:** Janssen Cilag N.V./S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-11
- **Primary completion:** 2015-06-24
- **Final completion:** 2015-06-24
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02448004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02448004, "Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02448004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*